Ribi ImmunoChem Research Incsaid Baxter Travenol Laboratories Inc's Travenol LaboratoriesInc unit will evaluate whether one of its products can be usedto prevent infectious disease.    Under an agreement, Ribi said Travenol will conduct studieswith the product, monophosphoryl lipid A, and will have theoption to pursue a woldwide license for the product.    Ribi said the product is used in combination with otheragents in experimental treatments to boost the function of theimmune system in patients suffering from malignant melanoma andother cancers. Reuter&#3;